Inhaltsangabe

PREFACE xxi

ACKNOWLEDGMENTS xxiii

PART 1 GENERAL THEMES

1 Introduction 3

2 Origins and Context of Counterfeiting in Healthcare 7

3 A Snapshot of the Problem 15

4 Risks and Costs of Counterfeit Pharmaceuticals 21

5 Anti-Counterfeiting Definitions 35

6 Protecting and Educating Consumers 49

7 Business Risks and Strategy 57

8 Government Issues 65

9 Intellectual Property and Anti-Counterfeiting 73

10 Traceability or Authentication? 81

PART 2 AUTHENTICATION

11 What Is Authentication? 87

12 Authentication of the Person 93

13 Authentication of Bulk Products 97

14 On-Dose and In-Dose Authentication 103

15 Analytical Detection of Counterfeit Dosage Forms 113

16 The Role of Packaging 127

17 Printing Technologies 135

18 Security Labels 145

19 Holograms and DOVIDs 153

20 Specialty Inks 159

21 Covert Taggants and Forensic Markers 165

22 General Conclusions on Printed Packaging and Security Labels 169

23 Security of Primary Packaging 173

24 Security of Secondary Packaging 193

25 Analytical Methods for Packaging 205

26 Security of Other Packaging Types 209

27 Bulk Packaging and Transport Security 215

PART 3 PRODUCT TRACKING

28 Rationale for Pharmaceutical Tracking 225

29 Tracking Technologies 231

30 Data Format, Generation, and Storage 247

31 Management of Packaging Hierarchy 257

32 Geographical Perspectives 269

33 Product Tracking in Other Industries 291

34 Supply Chain Security Processes 295

35 Implementing Anti-Counterfeiting Initiatives--Practical Issues 303

PART 4 CONCLUSIONS AND THE FUTURE

36 Where Do We Go from Here? 313

37 New Models, New Approaches 321

38 Selected Examples from Around the World 329

PART 5 FURTHER RESOURCES

A PATIENT'S GUIDE TO AVOIDING COUNTERFEIT DRUGS 337

NOTES AND REFERENCES 343

GLOSSARY 363

INFORMATION SOURCES 379

DRUG REGULATORS 385

INDEX 391

Klappentext

This book overviews and integrates the business and technical issues that pharmaceutical companies need to know in order to combat the major global problem of counterfeit medicines. In addition to discussion of the problems, the author Davison addresses analytical techniques scientists use to detect counterfeits and presents some possible solutions to the threat of counterfeit medical products. Coverage moves from basic overview of the problem, costs / risks to consumers (toxic products, mistrust of drug companies) and business (revenue loss, public trust), government oversight and regulation, authentication strategies (packaging, analytical techniques), product tracking and supply chain, and case studies from around the globe.

Sonstiges

Lieferung vom Verlag mit leichten Qualitätsmängeln möglich